Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats. (Q42492136)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16539687%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16539687%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16539687%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Roberto Stancampiano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16539687%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M. Angela Cenci Nilsson

6

object named as

M A Cenci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16539687%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Hanna S Lindgren

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16539687%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Martin Lundblad

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16539687%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Fabio Fadda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16539687%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

1 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16539687%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neurochemistry

18 January 2020

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16539687%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16539687%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16539687%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

1718-1727

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16539687%20AND%20SRC:MED&resulttype=core&format=json

Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03696.X

Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03696.X

Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03696.X

L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03696.X

Animal models of neurological deficits: how relevant is the rat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03696.X

Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03696.X

Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03696.X

Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03696.X

Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03696.X

The origin of motor fluctuations in Parkinson's disease: importance of dopaminergic innervation and basal ganglia circuits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03696.X

Kinetic analysis of blood-brain barrier transport of amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03696.X

Human brain dopamine metabolism in levodopa-induced dyskinesia and wearing-off

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03696.X

L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03696.X

Compensations after lesions of central dopaminergic neurons: some clinical and basic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.03696.X